Status:
RECRUITING
Healthy Living With Online suPport & Education for Cardiovascular Disease in the Primary Care Setting
Lead Sponsor:
Nanyang Technological University
Collaborating Sponsors:
National University of Singapore
National University Health System, Singapore
Conditions:
Cardiovascular Diseases (CVD)
Eligibility:
All Genders
30-74 years
Phase:
NA
Brief Summary
This pragmatic four-arm (1:1:1:1) parallel cluster randomised controlled trial (cRCT) aims to evaluate the effectiveness of reducing the risk of cardiovascular disease (CVD) through three combinations...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age 30-74
- Based in Singapore for the duration of study participation (i.e., 6 months)
- Able to read and understand English
- Have access to and is comfortable using a smartphone
- For patients with diabetes, their LDL has to be at least 2.6 mmol/L
- For patients without diabetes, their LDL has to be at least 3.4 mmol/L
- Exclusion Criteria
- Have existing heart disease diagnosis or a prior history of any of the following: Angina, Cardiac arrhythmia, Coronary artery disease, Heart failure, Myocardial infarction, Peripheral vascular disease, Revascularisation, Stroke, Transient ischaemic attack
- Patients diagnosed with chronic kidney disease: i.e., eGFR \<60ml/min/1.73㎡ OR uACR ≥ 3mg/mmol (30mg/g) OR uPCR \>15mg/mmol (150mg/g)
- Patients with serious mental illness (i.e., require assistance in daily activities due to the mental illness)
- Pregnant or planning to be pregnant in the next six months
- Unable to give informed consent
- Diagnosed with a terminal illness or expected life expectancy of less than 12 months
- Patients with triglyceride levels of ≥ 4.5 mmol/L
- Patients on chemotherapy course during the study or less than one month prior to participating in the study
- Patients on long-term oral steroids
- Patients who are already involved in other HOPE studies (e.g. HOPE-Virtual study)
Exclusion
Key Trial Info
Start Date :
January 18 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2024
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT06099353
Start Date
January 18 2024
End Date
October 30 2024
Last Update
May 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lee Kong Chian School of Medicine, NTU
Singapore, Singapore